Loading...

BioSyent Inc.

BIOYF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$8.39
$-0.06(-0.71%)

BioSyent Inc. (BIOYF) Stock Overview

Explore BioSyent Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 75.7/100

Key Financials

Market Cap96.2M
P/E Ratio16.57
EPS (TTM)$0.49
ROE0.22%
Fundamental Analysis

AI Price Forecasts

1 Week$8.80
1 Month$9.59
3 Months$9.14
1 Year Target$9.72

BIOYF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BioSyent Inc. (BIOYF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 41.18, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $9.72.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 16.57 and a market capitalization of 96.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;